Nicolas Marincek

1.2k citations

11 papers · 944 indexed · 1 hit paper · h-index 10

Epidemiology top 5%
Oncology top 5%
Neurology top 2%
Radiology, Nuclear Medicine and Imaging top 10%
Endocrinology, Diabetes and Metabolism

Co-authors: Martin A. Walter Matthias Briel Jan Müller‐Brand Philippe Brunner Christoph Rochlitz Christian Schindler Helmut R. Mäcke Helmut Rasch
Topics: Neuroendocrine Tumor Research Advances (10 papers)Lung Cancer Research Studies (8 papers)Neuroblastoma Research and Treatments (7 papers)
Cited by: Neurology Oncology Epidemiology
Journals: Journal of Clinical Oncology Biomaterials Journal of Nuclear Medicine
Partner nations: Switzerland United States Canada

In The Last Decade

Nicolas Marincek

11 papers receiving 937 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [⁹⁰Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers

2011 452 citations Philippe Brunner, Nicolas Marincek et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Nicolas Marincek

Since Specialization

Citations

This map shows the geographic impact of Nicolas Marincek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Marincek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Marincek more than expected).

Fields of papers citing papers by Nicolas Marincek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Marincek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Marincek. The network helps show where Nicolas Marincek may publish in the future.

Co-authorship network of co-authors of Nicolas Marincek

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Marincek. A scholar is included among the top collaborators of Nicolas Marincek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Marincek. Nicolas Marincek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine Tumors 2016 ·Journal of Nuclear Medicine ·(unknown),Piotr Radojewski,(unknown),Rebecca A. Dumont,Nicolas Marincek,Attila Kollár,Philippe Brunner,Jan Beyersmann,Jan Müller‐Brand,Helmut R. Maëcke,Markus Laimer,Martin A. Walter	7
2	Upregulation of Key Molecules for Targeted Imaging and Therapy 2016 ·Journal of Nuclear Medicine ·Vincent Taelman,Piotr Radojewski,Nicolas Marincek,Anat Ben-Shlomo,(unknown),(unknown),Aurel Perren,Christoph Stettler,Thomas Krause,Lorenz Meier,Renzo Cescato,Martin A. Walter	57
3	The prognostic and predictive value of sstr2-immunohistochemistry and sstr2-targeted imaging in neuroendocrine tumors 2016 ·European Journal of Nuclear Medicine and Molecular Imaging ·Philippe Brunner,(unknown),Katharina Glatz,Lukas Bubendorf,Piotr Radojewski,(unknown),Nicolas Marincek,(unknown),(unknown),Rebecca A. Dumont,Helmut R. Maëcke,Jan Müller‐Brand,Matthias Briel,Anja Schmitt,Aurel Perren,Martin A. Walter	54
4	Towards tailored radiopeptide therapy 2015 ·European Journal of Nuclear Medicine and Molecular Imaging ·Piotr Radojewski,Rebecca A. Dumont,Nicolas Marincek,Philippe Brunner,Helmut R. Mäcke,Jan Müller‐Brand,Matthias Briel,Martin A. Walter	14
5	Somatostatin Receptor–Targeted Radiopeptide Therapy with ⁹⁰Y-DOTATOC and ¹⁷⁷Lu-DOTATOC in Progressive Meningioma: Long-Term Results of a Phase II Clinical Trial 2015 ·Journal of Nuclear Medicine ·Nicolas Marincek,Piotr Radojewski,Rebecca A. Dumont,Philippe Brunner,Jan Müller‐Brand,Helmut R. Maëcke,Matthias Briel,Martin A. Walter	65
6	Survival after somatostatin based radiopeptide therapy with (90)Y-DOTATOC vs. (90)Y-DOTATOC plus (177)Lu-DOTATOC in metastasized gastrinoma. 2015 ·PubMed ·Rebecca A. Dumont,(unknown),Nicolas Marincek,Philippe Brunner,Piotr Radojewski,Christoph Rochlitz,Jan Müller‐Brand,Helmut R. Maëcke,Matthias Briel,Martin A. Walter	27
7	Indium-111 labeled gold nanoparticles for in-vivo molecular targeting 2014 ·Biomaterials ·(unknown),(unknown),(unknown),Vincent Taelman,Nicolas Marincek,Thomas Krause,Lorenz Meier,Martin A. Walter	39
8	Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation study 2013 ·Journal of Translational Medicine ·Nicolas Marincek,(unknown),Philippe Brunner,Christian Schindler,Michael Koller,Christoph Rochlitz,Jan Müller‐Brand,Helmut R. Maëcke,Matthias Briel,Martin A. Walter	21
9	Somatostatin-based radiopeptide therapy with [177Lu-DOTA]-TOC versus [90Y-DOTA]-TOC in neuroendocrine tumours 2013 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown),(unknown),Nicolas Marincek,Philippe Brunner,Michael Koller,(unknown),Helmut R. Maëcke,Jan Müller‐Brand,Christoph Rochlitz,Matthias Briel,Christian Schindler,Martin A. Walter	61
10	Cohort Study of Somatostatin-Based Radiopeptide Therapy With [⁹⁰Y-DOTA]-TOC Versus [⁹⁰Y-DOTA]-TOC Plus [¹⁷⁷Lu-DOTA]-TOC in Neuroendocrine Cancers 2012 ·Journal of Clinical Oncology ·(unknown),(unknown),Nicolas Marincek,Philippe Brunner,Michael Koller,Christian Schindler,(unknown),Helmut R. Mäcke,Jan Müller‐Brand,Christoph Rochlitz,Matthias Briel,Martin A. Walter	147
11	Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [⁹⁰Y-DOTA]-TOC in Metastasized Neuroendocrine Cancersbreakdown → 2011 ·Journal of Clinical Oncology ·(unknown),Philippe Brunner,Nicolas Marincek,Matthias Briel,Christian Schindler,Helmut Rasch,Helmut R. Mäcke,Christoph Rochlitz,Jan Müller‐Brand,Martin A. Walter	452

About Nicolas Marincek

Nicolas Marincek is a scholar working on Neurology, Oncology and Epidemiology, having authored 11 papers that have together received 944 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (10 papers), Lung Cancer Research Studies (8 papers) and Neuroblastoma Research and Treatments (7 papers). The work is most often cited by research in Neurology (546 citations), Oncology (662 citations) and Epidemiology (792 citations). Nicolas Marincek has collaborated with scholars based in Switzerland, United States and Canada. Frequent co-authors include Martin A. Walter, Matthias Briel, Jan Müller‐Brand, Philippe Brunner, Christoph Rochlitz, Christian Schindler, Helmut R. Mäcke, Helmut Rasch, Helmut R. Maëcke and Piotr Radojewski. Their work appears in journals such as Journal of Clinical Oncology, Biomaterials and Journal of Nuclear Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact